Turn Therapeutics Inc. (TTRX) stock
TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.89+0.34 (+3.98%)
Close on Nov 18, 2026Market cap $264.82MP/E –Yield –
Turn Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Turn Therapeutics's operating income for the twelve months ending Sep 30, 2026 was -$7.05M. For fiscal 2025 it was -$5.86M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.86M | – |
| FY2024 | Dec 31, 2024 | -$1.80M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.98M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.63M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.25M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.19M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.91M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.37M | – |
| Q1 FY2025 | Mar 31, 2025 | -$385.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$328.96K | – |
| Q3 FY2024 | Sep 30, 2024 | -$672.99K | – |
See a number that looks wrong?